Key result
Re-do Commando procedure successfully treats mitral valve dehiscence using bioprosthetic mitral and aortic homograft.
Why the study?
The Commando procedure is indicated for complex valve pathology including mitral valve dehiscence after prior surgery, but reports on re-do procedures with bioprosthetic mitral valve and aortic homograft are limited.
Case Report (n=1)
Demonstrates the technical feasibility of a re-do Commando procedure using a bioprosthetic mitral valve and aortic homograft for mitral valve dehiscence.
Answers are grounded in this paper and cite their sources.
Supports feasibility of re-do Commando in one case; leaves open durability, safety, and generalizability.
The Commando procedure, aortic and mitral valve replacement with aortomitral junction reconstruction, first described by Tirone David in 1997, is indicated in infective endocarditis with abscess, severe mitral annular calcification, lack of annular tissue to sew to in the setting of reoperation, and to prevent patient-prosthesis mismatch. Here we report a true re-do Commando procedure for mitral valve dehiscence using a bioprosthetic mitral valve and aortic homograft.
No takes yet. Share an insight, caveat, or question.
Higa et al. (2024) conducted a case report in Mitral valve dehiscence from prior Commando procedure (n=1). Re-do Commando procedure with bioprosthetic mitral valve and aortic homograft was evaluated. A true re-do Commando procedure using a bioprosthetic mitral valve and aortic homograft was reported for a patient with mitral valve dehiscence.
Synapse has enriched 10 related papers. Consider them for comparative context: